CD44/Folate Dual Targeting Receptor Reductive Response PLGA-Based Micelles for Cancer Therapy
In this study, a novel poly (lactic-co-glycolic acid) (PLGA)-based micelle was synthesized, which could improve the therapeutic effect of the antitumor drug doxorubicin hydrochloride (DOX) and reduce its toxic and side effects. The efficient delivery of DOX was achieved by active targeting mediated...
Saved in:
Main Authors: | Ru Zhang (Author), Yunying Jiang (Author), Linkun Hao (Author), Yang Yang (Author), Ying Gao (Author), Ningning Zhang (Author), Xuecheng Zhang (Author), Yimin Song (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Folate receptor-targeted mixed polysialic acid micelles for combating rheumatoid arthritis: in vitro and in vivo evaluation
by: Nan Zhang, et al.
Published: (2018) -
Hyaluronic Acid-Conjugated PLGA Nanoparticles Alleviate Ulcerative Colitis via CD44-Mediated Dual Targeting to Inflamed Colitis Tissue and Macrophages
by: Shwe Phyu Hlaing, et al.
Published: (2022) -
Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics
by: Gul-, et al.
Published: (2021) -
Tetracycline-grafted mPEG-PLGA micelles for bone-targeting and osteoporotic improvement
by: Yunduan Que, et al.
Published: (2022) -
The importance of interaction between hyaluronic acid and CD44 receptor
by: Carlos Roberto Antonio, et al.
Published: (2021)